Read by QxMD icon Read


Carlos Cabrera López, Ciro Casanova Macario, José María Marín Trigo, Juan P de-Torres, Rebeca Sicilia Torres, Jesús María González, Francesca Polverino, Miguel Divo, Víctor Pinto Plata, Javier Zulueta, Francisco Javier Callejas, Bartolomé Celli
INTRODUCTION: The Spanish COPD guidelines (GesEPOC) have been recently modified. The aim of this study is to assess this revision and evaluate the prognosis of patients according to the new classification of severity. METHODS: A total of 700 COPD patients (83.9% men) were prospectively followed up for a mean period of 5 years in tertiary hospitals in Spain and the USA. Anthropometric data, lung function tests, dyspnea (according to the mMRC scale), BODE and Charlson index were collected...
February 1, 2019: Archivos de Bronconeumología
Rafael Golpe, María Suárez-Valor, Iria Veiga-Teijeiro, Alejandro Veres-Racamonde, Luis A Pérez-de-Llano
No abstract text is available yet for this article.
January 11, 2019: Archivos de Bronconeumología
Eulogio Pleguezuelos, Elena Gimeno-Santos, Carmen Hernández, María Del Carmen Mata, Leopoldo Palacios, Pascual Piñera, Jesús Molina, Eusebi Chiner, Marc Miravitlles
Non-pharmacological treatment is essential in patients with chronic obstructive pulmonary disease (COPD), but this treatment is sometimes not given the importance it deserves. Patients diagnosed with COPD should benefit from comprehensive care services. These services comprise a protocolized set of actions aimed at covering the health needs of the patient, taking into account their environment and circumstances. Pulmonary rehabilitation is one of the essential components of non-pharmacological treatment in comprehensive COPD care services...
September 18, 2018: Archivos de Bronconeumología
Myriam Calle Rubio, Juan Luis Rodríguez Hermosa, Juan José Soler-Cataluña, José Luis López-Campos, Bernardino Alcazar Navarrete, Joan B Soriano, José Miguel Rodríguez Gónzalez-Moro, Manuel E Fuentes Ferrer, Marc Miravitlles
INTRODUCTION: EPOCONSUL is the first national audit to analyze medical care for COPD in pulmonology departments in Spain. The main objective was to perform a retrospective analysis to determine the distribution of GesEPOC 2017 COPD risk levels and to evaluate clinical activity according to the new recommendations. MATERIAL AND METHODS: This is a cross-sectional clinical audit in which consecutive COPD cases were recruited over one year. The study evaluated risk and clinical phenotype according to GesEPOC 2017, and their correlation with the clinical interventions employed...
May 2018: Archivos de Bronconeumología
Myriam Calle Rubio, Ricard Casamor, Marc Miravitlles
BACKGROUND: The Spanish Guidelines for COPD (GesEPOC) describe four clinical phenotypes: non-exacerbator (NE), asthma-COPD overlap syndrome (ACO), frequent exacerbator with emphysema (EE), and exacerbator with chronic bronchitis (ECB). The objective of this study was to determine the frequency of COPD phenotypes, their clinical characteristics, and the availability of diagnostic tools to classify COPD phenotypes in clinical practice. MATERIALS AND METHODS: This study was an epidemiological, cross-sectional, and multi-centered study...
2017: International Journal of Chronic Obstructive Pulmonary Disease
José Luis Lopez-Campos, Eduardo Marquez-Martín, Francisco Ortega-Ruiz
No abstract text is available yet for this article.
June 2017: Archivos de Bronconeumología
Juan P de-Torres, Jose M Marin
No abstract text is available yet for this article.
June 2017: Archivos de Bronconeumología
Vicente Plaza, Francisco Álvarez, Myriam Calle, Ciro Casanova, Borja G Cosío, Antolín López-Viña, Luís Pérez de Llano, Santiago Quirce, Miguel Román-Rodríguez, Juan José Soler-Cataluña, Marc Miravitlles
Following a proposal by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), sponsor of the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA), authors of both papers have unified the criteria for the diagnosis of asthma-COPD overlap syndrome (ACOS). This consensus defines ACOS as the presence in a given patient of three elements: significant smoking exposure, chronic airflow limitation and asthma. Diagnosis is confirmed when a patient (35years of age or older), smoker or ex-smoker of more than 10 pack-years, presents airflow limitation (post-bronchodilator FEV1/FVC<0...
August 2017: Archivos de Bronconeumología
Aurelio Arnedillo Muñoz
No abstract text is available yet for this article.
June 2017: Archivos de Bronconeumología
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B Soriano, Julio Ancochea
The clinical presentation of chronic obstructive pulmonary disease (COPD) varies widely, so treatment must be tailored according to the level of risk and phenotype. In 2012, the Spanish COPD Guidelines (GesEPOC) first established pharmacological treatment regimens based on clinical phenotypes. These regimens were subsequently adopted by other national guidelines, and since then, have been backed up by new evidence. In this 2017 update, the original severity classification has been replaced by a much simpler risk classification (low or high risk), on the basis of lung function, dyspnea grade, and history of exacerbations, while determination of clinical phenotype is recommended only in high-risk patients...
June 2017: Archivos de Bronconeumología
Silvia García García, Luis Carazo Fernández, Javier Juan García, José Cesáreo Naveiro Rilo
OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients aged 40-85 from León were randomly selected from Primary Care database, MEDORA. PARTICIPANTS: 5222 eligible COPD patients were collected from MEDORA database...
December 2017: Atencion Primaria
Borja G Cosio, Joan B Soriano, Jose Luis López-Campos, Myriam Calle, Juan José Soler, Juan Pablo de-Torres, Jose Maria Marín, Cristina Martínez, Pilar de Lucas, Isabel Mir, Germán Peces-Barba, Nuria Feu-Collado, Ingrid Solanes, Inmaculada Alfageme
RATIONALE: The Spanish guideline for COPD (GesEPOC) recommends COPD treatment according to four clinical phenotypes: non-exacerbator phenotype with either chronic bronchitis or emphysema (NE), asthma-COPD overlap syndrome (ACOS), frequent exacerbator phenotype with emphysema (FEE) or frequent exacerbator phenotype with chronic bronchitis (FECB). However, little is known on the distribution and outcomes of the four suggested phenotypes. OBJECTIVE: We aimed to determine the distribution of these COPD phenotypes, and their relation with one-year clinical outcomes...
2016: PloS One
R García-Palenzuela, R Timiraos Carrasco, M I Gómez-Besteiro, G Lavia, M Lago Pose, B Lara
The prevalence of chronic obstructive pulmonary disease (COPD) in Spain is 10.2%. Although tobacco is the main aetiological factor, biomass smoke exposure and alpha-1 antitrypsin deficiency (AATD) have also been related to its development. AATD is a genetic condition which could be causing 2-3% of COPD cases. The aim of this cross-sectional descriptive study was to exclude the existence of AATD in a population of COPD patients from CS Culleredo, A Coruña. The thick blood drop test on blotting paper, as well as the analysis of the mutations PI*S and PI*Z of the gene SERPINA 1 by the analysis of denaturing gradients after simultaneous amplification related to PCR (polymerase chain reaction)...
May 2017: Semergen
José Luis Izquierdo Alonso
No abstract text is available yet for this article.
September 2016: Archivos de Bronconeumología
Marc Miravitlles
No abstract text is available yet for this article.
January 2016: Archivos de Bronconeumología
Marc Miravitlles, Alicia Huerta, José Alberto Fernández-Villar, Bernardino Alcázar, Guillermo Villa, Carles Forné, Maribel Cuesta, Carlos Crespo, Francisco García-Río
BACKGROUND: To determine generic utilities for Spanish chronic obstructive pulmonary disease (COPD) patients stratified by different classifications: GOLD 2007, GOLD 2013, GesEPOC 2012 and BODEx index. METHODS: Multicentre, observational, cross-sectional study. Patients were aged ≥40 years, with spirometrically confirmed COPD. Utility values were derived from EQ-5D-3 L. Means, standard deviations (SD), medians and interquartile ranges (IQR) were computed based on the different classifications...
2014: Health and Quality of Life Outcomes
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Riesco, Juan Antonio Trigueros, Pascual Piñera, Adolfo Simón, Juan Luis Rodríguez-Hermosa, Esther Marco, Daniel López, Ramon Coll, Roser Coll-Fernández, Miguel Ángel Lobo, Jesús Díez, Joan B Soriano, Julio Ancochea
No abstract text is available yet for this article.
January 2014: Archivos de Bronconeumología
Juan Antonio Trigueros Carrero
Chronic obstructive pulmonary disease (COPD) is a chronic disorder whose clinical course may be punctuated by exacerbations characterized by a sudden symptom worsening beyond the expected daily variations. Exacerbations bear clinical and prognostic relevance, and may result in marked functional and clinical deterioration. The varying presentations of COPD mean that exacerbations, although more frequent in patients with severe or very severe disease, may occur regardless of the degree of functional impairment...
April 2013: Expert Review of Respiratory Medicine
Jesús Molina París
The main objectives in the management of chronic disorders such as chronic obstructive pulmonary disease (COPD) are: to suppress or minimize symptoms; to prevent and reduce exacerbations; to avoid limitations in activities of daily living, and thus to enable the patient to lead a normal, or nearly normal, life. COPD has become a serious public-health concern. The disease, which may be life-threatening if not properly managed, often goes undiagnosed. COPD accounts for significant healthcare, social and personal costs, as it can cause disability and lead to marked impairment in patients' quality of life...
April 2013: Expert Review of Respiratory Medicine
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Pascual Piñera, Adolfo Simón, Juan Antonio Riesco, Julio Ancochea, Joan B Soriano
After the development of the COPD Strategy of the National Health Service in Spain, all scientific societies, patient organisations, and central and regional governments formed a partnership to enhance care and research in COPD. At the same time, the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) took the initiative to convene the various scientific societies involved in the National COPD Strategy and invited them to participate in the development of the new Spanish guidelines for COPD (Guía Española de la EPOC; GesEPOC)...
March 2013: Primary Care Respiratory Journal: Journal of the General Practice Airways Group
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"